SARS-CoV-2 & RSV

Is it RSV? Is it COVID-19? Actionable results in minutes.

Verify potential infection and help guide infection control measures quickly with a rapid microfluidic assay that provides actionable results in 12 minutes, for patients suspected of RSV and/or COVID-19.

Test benefits

  • Microfluidic immunofluorescence assay
  • Optimize patient and clinical flow - 1 sample, 2 results, 12 minutes
  • Helps guide infection control measures quickly
  • Sample Type: nasal swab
  • Prepared sample can also be used with LumiraDx SARS-Cov-2 & Flu A/B Test
  • Easy to implement at point of care
    • Time to result in as quick as 12 minutes
    • No refrigeration storage required: room temperature storage (2-30°C)
    • Minimal handling steps
    • Small and portable Instrument

Test workflow

The Instrument and Test Strips are integrated with several quality control checks to ensure the Instrument and Test are functioning correctly for every test run.

The workflow process is comprised of a simple sample prep along with step-by-step guidance of the Instrument to report a patient result in under 12 minutes from sample application.

SARS-CoV-2 & RSV workflow image
COMPLIANCE DOCUMENTS

Not all products are available in all countries and regions. Please check with your local LumiraDx sales representative or distributor for availability in specific markets. 

Bessere GesundheitErfahrungenOutcomes

Wir unterstützen ein gesünderes Leben für Einzelpersonen, Communities und die Gesellschaft als Ganzes.

Wir ermöglichen responsive, persönliche Beziehungen zwischen Patienten und Versorgungsteams.

Wir kontrollieren und senken Kosten zur Entlastung des Budgets von medizinischen Einrichtungen.

Informiert bleiben

FÜR NEWS ANMELDEN